CZ  |  EN  |  SK

Encapsulation of methotrexate in alginate & hyaluronic acid microbeads for controlled release in cancer treatment

BÜCHI Labortechnik AG

In the presented study of Genc &Butuktiryaki, Methotrexate (MTX) was encapsulated in alginate-hyaluronic acid microbeads which were prepared using the Inotech Encapsulator (pre-cursor of the BUCHI Encapsulators). MTX is an anti-metabolite and anti-folate drug used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid.
Encapsulation of MTX provides a mechanism for the controlled release of the drug; enabling the release of the required dose while also preventing interaction of the drug from oxygen, pH changes and other unfavourable conditions which can cause the drug to degrade before reaching its target area.
 

Download application Download application Application overview Contact us

Application Download Form

* These fields are mandatory.

** Please note that your personal data will be stored safely and in accordance with the General Data Protection Regulation (GDPR) (EU) 2016/679 on the protection of individuals in relationship with processing personal data and the free movement of such data You have the right to request from us to access all your personal data stored, rectify it, delete or limit the processing of personal data, as well as to withdraw your consent at any time Personal data will not be shared outside our group of companies, nor sold to other companies Personal data may be used for marketing and communication purposes until consent is revoked

See more Applications in:

Encapsulation

See more Applications related to:

Dryers & Encapsulators